Subscribe to our monthly newsletter to receive exclusive news updates and medical AI insights.
News
Featured News
DeepVessel 3D Visualization Processing Software Receives Regulatory Approval in China
Keya Medical has received regulatory approval in China for its DeepVessel 3D Visualization Processing Software. The AI-based software medical device is designed for visualization reading of multiphase CT images and 3D models.
Deep Learning-based CT-FFR Reduces the Need for Invasive Coronary Angiography
A new study conducted by researchers at the First Affiliated Hospital of Jinan University demonstrates that deep learning-based CT-FFR (DL-CTFFR) can reduce the need for invasive coronary angiography (ICA) and improve outcomes in patients with stable coronary artery disease (CAD).
Moving Toward a Coronary CTA-first Strategy: Current Evidence, Guidelines, & Recommendations
Evidence is building in support of a coronary CTA-first strategy for evaluating patients with stable coronary artery disease. Learn more about the current evidence, guidelines, and recommendations.
Dr. Kunlin Cao Named to 2021 Forbes China Up-and-Coming Businesswomen List
Keya Medical’s President of R&D, Dr. Kunlin Cao, has been recognized on the 2021 Forbes China Up-and-Coming Businesswomen list. The list highlights 20 accomplished women who have each played a significant role in shaping China’s business landscape.
The Value of Deep Learning-based CT-FFR in Detecting Coronary Stenosis & Predicting Outcomes
Researchers at Fuwai Hospital conducted a retrospective study to evaluate the performance of Keya Medical’s deep learning-based CT-FFR product in detecting hemodynamic changes in stenosis.
Putting the Spotlight on Women’s Hearts: Cardiovascular Disease in Women
Cardiovascular disease (CVD) remains the leading cause of death for women in the U.S. In honor of American Heart Month, we are highlighting the differences in women’s risk factors and primary prevention to help manage CVD in women.
Will New Value-based Care Regulations Spark Innovation?
On Jan. 19, two regulatory changes went into effect that intend to modernize the Physician Self-Referral Statute & the Anti-Kickback Statute, facilitating the shift to value-based care.
Keya Medical Raises $46M in Series D Round
Keya Medical has raised $46 million in Series D funding. This funding round was led by new and existing investors, including CICC Capital, Shanghai Artificial Intelligence Investment Fund, Qianhai Gaozu Asset Management Fund, and IN CAPITAL.
EACVI Best of Imaging: Advances in Cardiac CT
EACVI Best of Imaging introduced the latest advances in cardiac CT, promoting a patient-centric, multi-modality approach to cardiovascular disease diagnosis.
Keya Medical Closes $30 Million Series C Funding Round Led by IDG Capital
Keya Medical announced that it has completed a $30 Million Series C Funding Round led by IDG Capital, with participation from investors Alwin Capital, Source Code Capital, and Tasly Group.
Virtual Medical AI Events in November
We have compiled a list of free virtual events hosted by professional organizations that will take place in November, covering topics in cardiology, radiology, and AI.
Coronary CTA Reimbursement: Opportunities & Challenges
Examine the current challenges for coronary CTA reimbursement, the potential effects it will have on patient care, and what medical imagers can do to help improve reimbursement moving forward.
Keya Medical Awarded China Health Innovation Award at 2020 DEMO China
On Oct. 17 and 18, the Chengdu Science and Technology Bureau hosted the 2020 DEMO China Innovation Finals, bringing together leading companies across the country.
